Full Press Release Details
Biogen and Ionis report positive topline clinical data on investigational Alzheimer’s disease treatment at AAIC.
BIIB
Biogen and Ionis report positive topline clinical data on investigational Alzheimer’s disease treatment at AAIC
Key Takeaway: Biogen and Ionis report positive topline clinical data on investigational Alzheimer’s disease treatment at AAIC
Price reaction · baseline $325.4 (2021-07-23 close) · 2 other BIIB headline(s) in the window, move may be shared
day 0 close · peak
+2%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.8%
average across 15 past catalysts
Lead asset
Alefacept
Phase 3 · Chronic Plaque Psoriasis